Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 7, 2007
J Am Soc Nephrol 18: 707-718, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006030269

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2006030269v1
18/3/707    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jouret, F.
Right arrow Articles by Devuyst, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jouret, F.
Right arrow Articles by Devuyst, O.

Genetics and Development

Cystic Fibrosis Is Associated with a Defect in Apical Receptor–Mediated Endocytosis in Mouse and Human Kidney

François Jouret*, Alfred Bernard{dagger}, Cédric Hermans{ddagger}, Geneviève Dom§, Sara Terryn||, Teresinha Leal, Patrick Lebecque**, Jean-Jacques Cassiman{dagger}{dagger}, Bob J. Scholte{ddagger}{ddagger}, Hugo R. de Jonge{ddagger}{ddagger}, Pierre J. Courtoy§ and Olivier Devuyst*

* Division of Nephrology, {dagger} Department of Public Health, Unit of Industrial Toxicology and Occupational Medicine, {ddagger} Haemostasis and Thrombosis Unit, § Christian de Duve Institute of Cellular Pathology, Cell Unit, Department of Clinical Chemistry, and ** Department of Pneumology–Paediatrics, Université catholique de Louvain, Brussels, || Laboratory of Cell Physiology, Centrum voor Milieukunde, Universiteit Hasselt, Diepenbeek, and {dagger}{dagger} Center for Human Genetics, University of Leuven, Leuven, Belgium; and {ddagger}{ddagger} Departments of Biochemistry/Cell Biology, Erasmus University Medical Center, Rotterdam, The Netherlands

Address correspondence to: Dr. Olivier Devuyst, Division of Nephrology, Université catholique de Louvain, 10 Avenue Hippocrate, B-1200 Brussels, Belgium. Phone: +32-2-764-54-53; Fax: +32-2-764-54-55; E-mail: devuyst{at}nefr.ucl.ac.be

Received for publication March 24, 2006. Accepted for publication December 17, 2006.

Inactivation of the chloride channel cystic fibrosis transmembrane conductance regulator (CFTR) causes cystic fibrosis (CF). Although CFTR is expressed in the kidney, no overwhelming renal phenotype has been documented in patients with CF. This study investigated the expression, subcellular distribution, and processing of CFTR in the kidney; used various mouse models to assess the role of CFTR in proximal tubule (PT) endocytosis; and tested the relevance of these findings in patients with CF. The level of CFTR mRNA in mouse kidney approached that found in lung. CFTR was located in the apical area of PT cells, with a maximal intensity in the straight part (S3) of the PT. Fractionation showed that CFTR co-distributed with the chloride/proton exchanger ClC-5 in PT endosomes. Cftr–/– mice showed impaired 125I-beta2-microglobulin uptake, together with a decreased amount of the multiligand receptor cubilin in the S3 segment and a significant loss of cubilin and its low molecular weight (LMW) ligands into the urine. Defective receptor-mediated endocytosis was found less consistently in Cftr{Delta}F/{Delta}F mice, characterized by a large phenotypic heterogeneity and moderate versus mice that lacked ClC-5. A significant LMW proteinuria (and particularly transferrinuria) also was documented in a cohort of patients with CF but not in patients with asthma and chronic lung inflammation. In conclusion, CFTR inactivation leads to a moderate defect in receptor-mediated PT endocytosis, associated with a cubilin defect and a significant LMW proteinuria in mouse and human. The magnitude of the endocytosis defect that is caused by CFTR versus ClC-5 loss likely reflects functional heterogeneity along the PT.




This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
J. Wright, M. M. Morales, J. Sousa-Menzes, D. Ornellas, J. Sipes, Y. Cui, I. Cui, P. Hulamm, V. Cebotaru, L. Cebotaru, et al.
Transcriptional adaptation to Clcn5 knockout in proximal tubules of mouse kidney
Physiol Genomics, May 1, 2008; 33(3): 341 - 354.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Belge, P. Gailly, B. Schwaller, J. Loffing, H. Debaix, E. Riveira-Munoz, R. Beauwens, J.-P. Devogelaer, J. G. Hoenderop, R. J. Bindels, et al.
Renal expression of parvalbumin is critical for NaCl handling and response to diuretics
PNAS, September 11, 2007; 104(37): 14849 - 14854.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP